Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection

Álvaro H. Borges(Statens Serum Institut), Ronald T. Mitsuyasu(APLA Health), Sanjay Pujari, Peter Mugyenyi(Joint Clinical Research Centre), Mamta K. Jain(The University of Texas Southwestern Medical Center), Peré Domingo(Hospital de Sant Pau), Adrian Palfreeman(University of Leicester), Tim Read(Melbourne Sexual Health Centre), Michael Meulbroek, Margaret A. Johnson(The Royal Free Hospital), Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), Abdel G. Babiker(MRC Clinical Trials Unit at UCL), Timothy Wilkin(Cornell University), Keith Henry(Universität Hamburg), Jacqueline Neuhaus(University of Minnesota)
Clinical Infectious Diseases
September 8, 2016
10.1093/cid/ciw621
Cited by 93

Related Papers

Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
|The Journal of Infectious Diseases|2010|864
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
|AIDS|2014|597
Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
|New England Journal of Medicine|2011|541